[Recent progress and problems in percutaneous coronary intervention].
Yamaguchi
Toru
T
D015906:Angioplasty, Balloon, Coronary / Q000379:methods* / Q000639:trends*; D000925:Anticoagulants / Q000008:administration & dosage; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D003324:Coronary Artery Disease / Q000628:therapy*; D023903:Coronary Restenosis / Q000517:prevention & control; D016503:Drug Delivery Systems; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D017239:Paclitaxel / Q000008:administration & dosage; D011108:Polymers; D020123:Sirolimus / Q000008:administration & dosage; D015607:Stents / Q000009:adverse effects; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control; D014859:Warfarin / Q000008:administration & dosage
D000925:Anticoagulants; D000972:Antineoplastic Agents, Phytogenic; D007166:Immunosuppressive Agents; D011108:Polymers; D014859:Warfarin; D017239:Paclitaxel; D020123:Sirolimus